Innovate Healthcare: How AI changes radiologists' approach to stroke care

UC expert says strategic use of AI can augment, not replace human analysis

As artificial intelligence (AI) capabilities increase, there is sometimes concern that machine learning will replace the work done by human experts.

In the field of radiology and stroke care, however, radiologists see the progression of AI as an opportunity to bolster the work they do.

Achala Vagal, MD, vice chair of research and professor of radiology in the University of Cincinnati’s College of Medicine and a UC Health neuroradiologist, cowrote a recent editorial in the journal Radiology with Luca Saba, MD, of the University of Cagliari in Italy. Innovate Healthcare's Health Imaging, an online publication, recently highlighted the editorial, noting Vagal and Saba said that AI will not replace radiologists, but rather will "augment our intelligence and workflow."

The radiologists said AI is helpful in improving workflows, detecting issues the human eye cannot see and offering suggested decision-making support in time-sensitive triage scenarios, but AI being used as the standalone decision maker for treatments has led to medical errors. 

“It is important to understand the intended clinical use of the technology,” the doctors explained. “The best use case scenario is not autonomous AI, but rather AI partnered with human supervision.” 

Read the Innovate Healthcare article.

Read more about Dr. Vagal's current stroke recovery research.

Featured photo at top of brain scans. Photo/Ravenna Rutledge/University of Cincinnati.

Related Stories

1

UC biologist talks about 'pearmageddon'

March 16, 2026

WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.